PMID- 11311989 OWN - NLM STAT- MEDLINE DCOM- 20010726 LR - 20191104 IS - 0169-409X (Print) IS - 0169-409X (Linking) VI - 47 IP - 2-3 DP - 2001 Apr 25 TI - Roles of lipid polymorphism in intracellular delivery. PG - 139-48 AB - Lipids, which adopt nonbilayer phases, have fascinated researchers as to the functional roles of these components in biomembranes. In particular, lipids capable of adopting the hexagonal H(II) phase have received considerable attention because of the observation that such lipids can promote membrane fusion. In the rational design of lipid-based delivery systems, H(II) phase lipids have been employed to endow systems with fusogenic, membrane-destabilizing properties. We will outline the molecular basis for the polymorphic phase behavior of lipids and highlight some of the uses of nonbilayer lipids in the preparation of lipid-based delivery systems. In addition, a distinction will be drawn between lipid-based systems which rely on the inclusion of nonbilayer lipids for activity, and systems which contain components which actively promote formation of nonbilayer structure within biological membranes. FAU - Hafez, I M AU - Hafez IM AD - Department of Biochemistry and Molecular Biology, University of British Columbia, 2146 Health Sciences Mall, British Columbia V6T 1Z3, Vancouver, Canada. FAU - Cullis, P R AU - Cullis PR LA - eng PT - Journal Article PT - Review PL - Netherlands TA - Adv Drug Deliv Rev JT - Advanced drug delivery reviews JID - 8710523 RN - 0 (1,2-dioleoyl-glycero-3-phosphatidyl ethanolamine) RN - 0 (Glycerophospholipids) RN - 0 (Lipid Bilayers) RN - 0 (Lipids) RN - 0 (Liposomes) RN - 0 (Membrane Lipids) RN - 0 (Micelles) RN - 0 (Phosphatidylethanolamines) SB - IM MH - Glycerophospholipids/*chemistry/metabolism MH - Hydrogen-Ion Concentration MH - Lipid Bilayers/*chemistry/metabolism MH - Lipid Metabolism MH - Lipids/chemistry MH - Liposomes MH - *Membrane Fusion/physiology MH - Membrane Lipids/*chemistry/metabolism MH - *Micelles MH - *Phosphatidylethanolamines RF - 78 EDAT- 2001/04/20 10:00 MHDA- 2001/07/28 10:01 CRDT- 2001/04/20 10:00 PHST- 2001/04/20 10:00 [pubmed] PHST- 2001/07/28 10:01 [medline] PHST- 2001/04/20 10:00 [entrez] AID - S0169-409X(01)00103-X [pii] AID - 10.1016/s0169-409x(01)00103-x [doi] PST - ppublish SO - Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):139-48. doi: 10.1016/s0169-409x(01)00103-x.